MetaCap

UroGen Pharma Insider Trades

NASDAQ: URGNHealth CareBiotechnology: Pharmaceutical PreparationsUSD

36.83-0.15 (-0.41%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
14 · $4.69M
Shares bought / sold
0 / 123.14K
Net activity
Net selling $4.7 million

UroGen Pharma insider activity

Over the last 12 months, UroGen Pharma insiders reported 30 transactions on SEC Form 4: 0 open-market purchases and 14 sales. Insiders bought $0 and sold $4.7 million worth of stock, for net insider selling of $4.7 million. The largest seller was Schoenberg Mark, with $4.5 million in reported sales.

The most recent filing shows Schoenberg Mark (Chief Medical Officer) selling 871 shares at $42.92 on Sep 8, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put URGN's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

URGN insider transactions

UroGen Pharma insider transactions
DateInsiderTypeSharesValueFiling
Sep 8, 2026Smith Jason DrewGeneral CounselSale1,519$64.62KForm 4
Sep 8, 2026Schoenberg MarkChief Medical OfficerSale871$37.38KForm 4
Sep 7, 2026Smith Jason DrewGeneral CounselOption exercise3,334—Form 4
Sep 7, 2026Schoenberg MarkChief Medical OfficerOption exercise1,667—Form 4
Aug 26, 2026Robinson James A. Jr.DirectorOption exercise2,000—Form 4
Aug 20, 2026Schoenberg MarkChief Medical OfficerSale60,677$2.85MForm 4
Jul 9, 2026Schoenberg MarkChief Medical OfficerSale10,000$400.00KForm 4
Jun 22, 2026Schoenberg MarkChief Medical OfficerSale10,000$350.10KForm 4
Jun 8, 2026Schoenberg MarkChief Medical OfficerSale5,222$142.56KForm 4
Jun 8, 2026Schoenberg MarkChief Medical OfficerOption exercise10,000—Form 4
May 26, 2026Robinson James A. Jr.DirectorOption exercise2,000—Form 4
May 8, 2026Schoenberg MarkChief Medical OfficerSale10,000$300.00KForm 4
Feb 3, 2026Schoenberg MarkChief Medical OfficerSale3,686$72.58KForm 4
Feb 3, 2026Schoenberg MarkChief Medical OfficerSale1,843$36.29KForm 4
Feb 3, 2026Schoenberg MarkChief Medical OfficerSale1,844$36.31KForm 4
Feb 3, 2026Smith Jason DrewGeneral CounselSale3,217$63.34KForm 4
Feb 3, 2026Smith Jason DrewGeneral CounselSale1,608$31.66KForm 4
Feb 3, 2026Smith Jason DrewGeneral CounselSale2,654$52.26KForm 4
Jan 31, 2026Schoenberg MarkChief Medical OfficerOption exercise3,334—Form 4
Jan 31, 2026Schoenberg MarkChief Medical OfficerOption exercise6,666—Form 4
Jan 31, 2026Schoenberg MarkChief Medical OfficerOption exercise3,333—Form 4
Jan 31, 2026Smith Jason DrewGeneral CounselOption exercise6,667—Form 4
Jan 31, 2026Smith Jason DrewGeneral CounselOption exercise3,333—Form 4
Jan 31, 2026Smith Jason DrewGeneral CounselOption exercise5,500—Form 4
Nov 26, 2025WEN LEANADirectorOption exercise2,000—Form 4
Nov 26, 2025Robinson James A. Jr.DirectorOption exercise2,000—Form 4
Nov 26, 2025Holden StuartDirectorOption exercise2,000—Form 4
Nov 26, 2025Wildman Daniel GeorgeDirectorOption exercise2,000—Form 4
Nov 26, 2025BUTITTA CYNTHIA MDirectorOption exercise2,000—Form 4
Nov 19, 2025Schoenberg MarkChief Medical OfficerSale10,000$250.00KForm 4
Oct 8, 2025Degnan ChrisChief Financial OfficerSale2,203$37.12KForm 4
Oct 8, 2025Degnan ChrisChief Financial OfficerOption exercise4,483—Form 4
Sep 8, 2025Schoenberg MarkChief Medical OfficerSale871$16.64KForm 4
Sep 8, 2025Smith Jason DrewGeneral CounselSale1,520$29.05KForm 4
Sep 7, 2025Schoenberg MarkChief Medical OfficerOption exercise1,667—Form 4
Sep 7, 2025Smith Jason DrewGeneral CounselOption exercise3,333—Form 4
Aug 11, 2025Schoenberg MarkChief Medical OfficerSale10,000$176.90KForm 4
Jul 28, 2025Schoenberg MarkChief Medical OfficerSale5,149$98.55KForm 4
Jul 28, 2025Schoenberg MarkChief Medical OfficerOption exercise10,000—Form 4
Jul 28, 2025Smith Jason DrewGeneral CounselSale7,522$143.97KForm 4
Jul 28, 2025Smith Jason DrewGeneral CounselOption exercise16,500—Form 4
Feb 26, 2025Robinson James A. Jr.DirectorOption exercise2,000—Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related